Last updated on: 24/09/2013
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: IMS Health
Name of data sourceIMS LifeLink: Hospital Disease Database - Belgium
Name under which the data source should be displayed in the inventory (e.g short name if one exists)IMS LifeLink: Hospital Disease Database - Belgium
Name of organisation
1) Department/research groupReal World Evidence Solutions
2) Organisation/affiliationIMS Health
Administrative Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
Scientific Contact
Title Dr
Last name Massoud
First name Toussi
Address line 15-7 place des Pyramides
Address line 2
Address line 3
CityParis La Défense
Postcode92088
CountryFrance
2. Description/category
Hospital medical summary data
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Hospital data
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
No
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
Discharge diagnosis
Yes
ICD 9 CM
Death
No
Procedures
Yes
ICD 9
Overdoses
Yes
ICD 9
Specific event
Description: -
Yes
ICD 9
5. Year of establishment
2001
6. Geographical origin of data
EEA/EFTA countries
Belgium
7. Demographical extent of data collection
Nation-wide
8. Age groups
17 years and under [Paediatrics]
preterm newborn infants
term newborn infants (0 to 27 days)
infants and toddlers (28 days to 23 months)
children (2 to 11 years)
adolescents (12 to 17 years)
18 to 45 years
46 to 64 years
65 years and over
65 to 75 years
76 years and over
9. Size of the source/catchment population
10,444,300
10 a. Total (cumulative) number of persons with actual data
1,100,000
10 b. Number of persons with active data collection in past calendar year
1,100,000
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
No
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
No
15. Charge/fee for data access
Yes
Special arrangements for academic purposes:
Yes
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Lamotte M, Chevalier P. The cost of diabetes complications in Belgium. ISPOR Europe
conference Nov 3-7 2012. PCV32. Nov 5 2012.
Lamotte M, Gerlier L, Chevalier P. The burden of diabetes mellitus in Belgium: a
retrospective database study. ISPOR Europe conference Nov 3-7 2012. PCV19. Nov 5 2012
Duran A, Spaepen E, Lamotte M, Walter E, Umuhire D, Lucioni C, Pinheiro B, Brosa M,
Kutikova L, Pujol B, Van BS, Annemans L. Cost Analysis: Treatment of chemotherapyinduced
anemia with erythropoiesis-stimulating agents in five European countries. J Med
Econ, 2012; 15 (3):409-18.
Leeuwenkamp O, Chevalier P, Lamotte M. Evaluation of the clinical and economic burden of
chronic constipation in Belgium. ISPOR 14th Annual European Congress, Madrid, Spain,
5-8 November 2011 (Poster).
Chevalier P, Lamotte M, Malfait M, Marciniak A. The incidence and outcome of febrile
neutropenia in different chemotherapy regimens for cancer patients in Belgium.
ESMO European
